WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...
WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...
WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Biological Medicines<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong> <strong>Vol</strong> <strong>20</strong>, <strong>No</strong>. 1, <strong>20</strong>06Preparation Activity StatusAntiseraAnti-dengue virus types 1,2, 3 100 units per serotype First <strong>WHO</strong> referenceand 4 serum per ampoule reagentAnti-Human platelet antigen-1a 100 International Units First International Standardper ampouleAnti-A blood grouping minimum <strong>No</strong> assigned activity; however First International Standardpotency reagenta 1 in 8 dilution should define therecommended minimum potencyspecification for anti-A bloodgrouping reagentsAnti-B blood grouping minimum <strong>No</strong> assigned activity; however a First International Standardpotency reagent1 in 4 dilution should define therecommended minimum potencyspecification for anti-B bloodgrouping reagentsCytokines, growth factors and endocrinological substancesVascular endothelial growth 13000 units per ampoule First <strong>WHO</strong> referencefactor, humanreagentKeratinocyte growth factor, 4000 units per ampoule First <strong>WHO</strong> referencehumanreagentKaratinocyte growth factor, 9000 units per ampoule First <strong>WHO</strong> reference(24–163), human reagentDiagnostic reagentsHIV–1 RNA 5.56log10 International Second InternationalUnits per vialStandardThese substances are held and distributed by the International Laboratory for Biological Standards,National Institute for Biological Standards and Control, Potters Bar, Herts., EN6 3QG,England.8
Change language